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ADOLESCENT DEPRESSION AND TYPE 1 DIABETES
Abstract
Problem: Depression among adolescents with Diabetes Mellitus type 1 (DM 1) is three
times more prevalent than adolescents without chronic disease. Diagnosis of
depression has been found to negatively affect the quality-of-care management, quality
of life, and results in an increase in hospital admissions with hypoglycemia or
hyperglycemia events.
Methods: A depression screening, the patient health questionnaire 9 (PHQ-9), a
validated screening tool for use among adolescents was implemented in this quality
improvement (QI) project. It was the first cycle of a plan-do-study-act (PDSA) cycle for
in a pediatric ICU. Adolescents between the ages of 12 – 18, were English speaking and
had been downgraded to a general status accommodation were the sample who meet
inclusion criteria of for this project. The project question was: What the is the impact
of implementation of the PHQ-9 on identification of depression in this population and if
needed, on referral to behavioral health?
Results: Data collected from seven adolescents found that depression was identified in
this population (n=4 or 57%) and one of these four patients showed suicidal tendencies.
The majority of those positive for depression were found to be white and female.
Limitations of the project included a small sample size and a short time of
implementation.
Implications for Practice: Future PDSA cycles should include establishing policies and
procedures for those found to be suicidal for placement within a facility, as well as
facilitating observational needs of the patient while in the hospital. Depression
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screening of this population should continue as it had a positive impact of detecting
depression among these adolescents.

Implementing a Depression Screening in a Pediatric Acute Care setting for Adolescents
with
Type 1 Diabetes
Diabetes Mellitus Type 1 (DM 1) is one of the most common chronic diseases
among adolescents. According to Marker et al. (2019), more than 167,000 children and
adolescents are affected by DM 1 in the United States, and the incidence is on the rise.
Picozzi & Deluca (2019) projected a 300% increase in DM 1 diagnoses by 2050. The
diagnosis of DM 1 comes with many lifestyle changes such as monitoring blood
glucose at least four times daily, carbohydrate to insulin ratio management, and
physical activity monitoring (Jaser et al., 2017). There are some differences in the
optimal glycemic index with the International Society for Pediatric and Adolescent
Diabetes (ISPAD) asserting the optimal hemoglobin A1c (HbA1c) of less than 7% [53
mmol/ mol] and the American Diabetes Association (ADA) guideline stating that the
optimal HbA1c is to be less than 7.5% [58 mmol/mol] (Marker et el., 2019).
Lack of adherence to a daily regimen to manage DM 1 among adolescents is
profound. Jaser et al. (2017) found that about 17% of adolescents with DM 1 were
meeting suggested targets for control. When an adolescent does not meet the
recommended targets, this places the child at increased risk of frequent hospitalizations
for hyperglycemia or hypoglycemia, and a decreased quality of life (QOL) (McGill et
al., 2018). The economic impact of this is staggering, and the healthcare costs annually
for diabetes management is $174 billion, with an additional $58 billion from
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productivity loss (Piccozi & Deluca, 2019). This number is expected to triple by 2050
with the estimated newly diagnosed DM 1 adolescents.
Additionally, among teens with a chronic disease, such as DM 1, depression
impacts between 8%-27%, which is roughly three times greater than the general
population (Picozzi & Deluca, 2019). Jaser et al. (2017) found that adolescents with
DM 1 had concerns of feeling different than peers, felt stressed regardless of glycemic
control, daily maintenance and parental “nagging”. When an individual experiences
daily stress in their life, it can affect physical and mental health. However, when an
individual with DM 1 has chronic stress, this affects glycemic control, creates issues
with increasing insulin resistance, and has an indirect negative impact upon diabetes
self-management (Jaser et al., 2017).
Marker et al. (2019) found that 5.7% of all adolescents have depression and
25%-30% of adolescents with DM 1 have an increase in depression symptoms. The
ADA and ISPAD recommend adolescents with DM 1 be screened annually for
depression, particularly those that are not meeting treatment goals such as HbA1c levels
and have frequent hospitalizations (Marker et al., 2019). There are several different
screening tools and questionnaires used for depression screenings among adolescents
including the Patient Health Questionnaire 9 (PHQ-9), Becks
Depression Inventory (BDI), Children’s Depression Inventory (CDI), and the Center for
Epidemiological Studies Depression Scale for Children (CES-DC) (Buchberger, 2016).
Regular implementation of screening tools helps identify those adolescents in need of
therapy, medication, and/or referral to a mental health provider which can have a
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positive impact on mental health and can lead to improved adherence to diabetes
management and ameliorate physical QOL (Picozzi & Deluca, 2019).
Recently, in a moderately sized pediatric unit in an urban midwestern pediatric
hospital, suicide screenings were implemented in adolescent patients but not depression
screenings. Implementing a depression screening at time of discharge from the
Pediatric Intensive Care Unit (PICU) may improve timely treatment of depression. The
purpose of this project is to administer the PHQ-9 to adolescent patients admitted to the
PICU with a diagnosis of DKA once the patient is downgraded to general status.
General status would be those that are near discharge, at baseline functionality, without
monitoring needs. The Institute for Healthcare Improvement's (IHI) plan-do-study-act
(PDSA) cycle was the framework selected for this project. The aim of the project is to
perform depression screening using the PHQ-9 on at least 50% of adolescents admitted
to the PICU with DKA during a three-month implementation period. The primary
outcome measure is PHQ-9 completion. Secondary outcome measures include the
PHQ-9 scores and referrals to behavioral health providers. The question this project
asks is: in pediatric patients aged 12-18 years admitted to the PICU with DKA, what is
the impact of PHQ-9 screening on identification and referrals to behavioral health?
Review of Literature
The search engines used for this literature review were PubMed, CINAHL, and
Cochrane review. The first searches within PubMed and CINAHL produced 1,958
(PubMed) and 7,970 (CINAHL) with the phrases diabet* AND depression AND
adolescen*. Another search was conducted on CINAHL using the phrases screening
tool AND depress* AND diabete* which resulted in 53 articles. On Cochrane review,
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the search phrase type 1 diabetes AND depression yielded 43 reviews. The search was
refined with the inclusion criteria of English language, adolescent ages 13-18, and free
full text. Exclusion criteria were developmental delay, non-English speaking, journals
that were older than 10-years and pre-existing psychiatric diagnosis. After reviewing
abstracts and full texts, exclusion criteria eliminated 6,098 articles. A total of 10
publications were selected for this review.
Of the 10 articles selected, three researched the effect of screening tools to
detect depression, four monitored how depression affected glycemic control, and three
studied how using specific therapies correlated with glycemic control. All of the
studies for review used at least one screening tool for depression. The PHQ-9
(Kroenke,Spitzer & William, 2001) and the CDI (Saoji et al., 2018) were the two most
used depression scales in the ten studies.
The PHQ-9 has a sensitivity of 88% and specificity of 88% for detecting
depression (Nefs et al., 2019). The PHQ-9 is comprised of questions regarding
depression and future suicide attempts using a Likert scale for 0 (not at all) to 3 (nearly
every day) for a possible score of 0-27. Higher scores mean more depressive symptoms
present (Marker et al., 2019). A score of greater than 5 indicates depression, and if the
suicide question were answered affirmatively, this is an automatic flag for depression
(Picozzi & Deluca, 2019). Kroenke, Spitzer & Williams (2001) implemented cut off
points for clinicians using the PHQ-9 to diagnose depression as: 5-9 indicates mild
depression, 10-14 indicates moderate depression, 15-19 indicates moderately severe
depression, and greater than or equal to 20 indicates severe depression. Marker et al.
(2019) used the PHQ-2/9 and found that 6.7% of the population had depressive
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symptoms and 3.1% of those had suicidal ideations. Similar results were found by
Picozzi & Deluca (2019) in which a total of 156 individuals with DM 1 were screened
with the PHQ-9 resulting in a rate of 19% diagnosed as depressed, and of those
screened, 75% were females. Watson et al. (2020) found the implementation of the
PHQ-4 followed by the PHQ-a (PHQ-9 revised for adolescents) was sufficient in
identifying depression in those with DM 1.
The other widely used depression screening tool was the CDI with a Cronbach
alpha of 0.70-0.86 showing strong internal consistency (McGill et al., 2018). Saoji et
al. (2018) reviewed the psychometrics of the CDI to establish this tool as effective at
screening for depression in children, particularly those with chronic illness. The means
of the CDI did not differ between those with chronic disease and the comparison peers
suggesting this tool is acceptable to screen for depression in those with chronic disease
(Saoji et al., 2018). This 27-item self-screening tool identifies cognitive, behavioral
and affective symptoms associated with depression with a possible score of 0-54 (Saoji
et al., 2018). Each of the 27 items are scored 0 to 2, and higher scores are associated
with more depressive symptoms present at the time of screening, with a score greater
than or equal to 19 representing the clinical range for a diagnosis of depression (Saoji et
al., 2018). Similar to the PHQ-9, the CDI gives the patient three separate responses to
choose from to best describe the thoughts and feelings that they had over the previous
two-week time frame (McGill et al., 2018). According to the American Diabetes
Association (2020), the screening tools are selected by the institution, as one is not
recommended over another. The PHQ-9, a free tool that available for parents or patients
to complete, is available via paper and pencil, or in electronic form, however, an in-

7

ADOLESCENT DEPRESSION AND TYPE 1 DIABETES
person interview is preferred (ADA, 2020). It can also be completed over the phone if
more convenient for the family (Marker et al., 2019). Marker et al. (2019) implemented
the PHQ-9 screening tool at a large midwestern children’s hospital, which included 13
tertiary and outreach pediatric endocrinology clinics. The goal of implementation was
to achieve 80% screening success in adolescents 12-21 years of age with DM 1 seen in
clinic for regular scheduled appointments (Marker et al., 2019). In total, 1,009
adolescents were screened over a two-year time frame (Marker et al., 2019). Of those,
6.7% patients had an elevated PHQ-9 score of greater than or equal to 5 indicating
greater depressive symptoms, and these findings were correlated to a higher average
blood glucose (Marker et al., 2018).
In a retrospective chart review, Duffus et al. (2019) studied The Strengths and
Difficulties Questionnaire (SDQ) scores completed during routine scheduled
appointments, on adolescents aged 11-17 years with a diagnosis of DM 1. Of the 135
patients screened during 2016, scores were compared to a normative group without
chronic illness (Duffus et al., 2019). Results showed that the group with DM 1 scored
significantly higher, indicating greater depression occurrence in this population with no
difference noted in the length of time since diagnosis (Duffus et al., 2019). Duffus et
al. (2019) concluded that screening should be implemented at time of diagnosis and on
a routine basis. Depression plays an important role on diabetes management, with
earlier diagnosis of depression having a greater impact on quality of care with
management (Duffus et al., 2019).
In a meta-analysis, Kongkaew et al. (2013) investigated the association of
depression and management of DM 1 in adolescents. Within the meta-analysis, six
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different screening tools throughout 19 studies were assessed on the effect of
depression and diabetes management. Kongkaew et al. (2013) determined there was a
moderate association between depression and non-adherence to diabetes management.
Results of this study helped to directly tie screening, diagnosis and management to
indicate screening for depression has a positive impact on glycemic control (Kongkaew
et al., 2013).
Mcgill et al., (2018) conducted an observational, prospective study evaluating
how depression affected adolescents’ self-management of diabetes. A total of 103
adolescents ages 10-17 were recruited into either the new onset DM 1 group or insulin
pump initiation group (McGill et al., 2018). The CDI was given at baseline then at one,
six and 12 months (McGill et al., 2018). No statistical difference in CDI scores
between the groups were found, however both groups had elevated CDI scores in the
first month when compared to the general population (McGill et al., 2019). New onset
patients had fewer improvements in HbA1c levels at the 6month time frame, indicating
that depressive symptoms can lead to poor glycemic control (McGill et al., 2019).
McGill et al. (2019) concluded that assessing and diagnosing depression early within
the diagnosis of DM 1 may improve glycemic control.
Picozzi & Deluca (2019) conducted a chart review to assess whether glycemic
control varies between those diagnosed with either DM 1 or DM 2 and depression to
those not diagnosed with depression. This retrospective case study reviewed charts of
214 endocrinology patients at St. Chistopher’s Hospital for Children in Philadelphia
(Picozzi & Deluca, 2019). One hundred fifty-six adolescents had a diagnosis of DM 1
and 24% were found to have depressive symptoms utilizing the PHQ-9 (Picozzi &
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Deluca, 2019). Those with depression were predominately female, younger age at
diagnosis, increased HbA1c levels, and had been diagnosed with DM 1 for a shorter
duration of time (Picozzi & Deluca, 2019). Diagnosing depression early in those with
DM 1 leads to earlier intervention, which is crucial during the adolescent years when
developmental stages such as identity vs role confusion can affect their sense of self
(Jaser et al., 2017).
Buchberger et al. (2016) reviewed 14 studies in a meta-analysis focusing on the
impact depression and anxiety has on glycemic control in adolescents diagnosed with
DM 1, as well the prevalence of depression and anxiety. Depression and anxiety were
prevalent among those with DM 1 based upon scores of CDI, DSRS, CES-D, and BDIY behavioral screenings (Buchbeger et al., 2016). A positive correlation was made
between diabetes management and depression scores with higher depression scores
resulting in a higher HbA1c level (Buchberger et al., 2016). In those with lower CDI
scores, optimal levels of HbA1c were recorded as well as improved QOL score
(Buchberger et al., 2016).
In a post hoc analysis, Hood, Rausch & Dolan (2011) screened 145 adolescents
for depression utilizing the CDI tool at a diabetes clinic at baseline and six months, also
obtaining HbA1c level and blood glucose monitoring (BGM). The increase in
depressive symptoms at six months was associated with increased HbA1c levels in
which Hood, Rausch & Dolan (2011) estimated that for every 0.5% increase in HbA1c
levels, a CDI score increased 5 points, as well as a one fewer BGM was associated.
These results suggest implementation of screening tools, along with coping strategies
can improve diabetes management (Hood, Rausch & Dolan, 2011). Jaser et al. (2017)
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studied coping strategies effect on depressive symptoms, QOL measures and glycemic
control. One hundred seventeen adolescents completed the Responses to Stress
Questionnaire (RSD) DM 1 version to evaluate stress, and the Quality of Life Inventory
(QLI) and the CDI for measurement of depression (Jaser et al., 2017). Jaser at al.
(2017) found higher levels of stress indicated poorer QOL and glycemic control.
Adolescents reporting diabetes related stress with a mean score of 11.3 (+ 4.6) at
baseline, increased 15% in the population depressed at 12 months from 9% at 6 months
(Jaser et al., 2017). A bi directional correlation of less use of primary coping skills and
secondary coping skills correlated with higher levels of stress in the adolescent (Jaser et
al., 2017). Intervening with primary (problem solving, emotional expression) and
secondary (positive thinking, cognitive restructuring, distraction) coping skills after
depression screening will benefit the adolescent with adherence to diabetes
management (Jaser et al., 2017).
In a randomized control trial, 94 patients with DM 1 who were diagnosed with
depression utilizing the BDI-II, were randomized into groups for mindfulness cognitive
therapy (MBCT), cognitive behavior therapy (CBT) or a wait list control group (Tovote
et al., 2014). Tovote et al. (2014) found that both MBCT and CBT groups had
statistically significant fewer depressive symptoms post measurement when compared
to the waitlisted control group. Both the MBCT and CBT groups showed improvement
in levels of well-being, anxiety, and distress related to diabetes management (Tovote et
al., 2014).
Weissberg-Benchell et al. (2016) constructed a randomized control trial
comparing depressive symptoms with implementation of PENN Resiliency Program
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(PRP) and a control group. Two hundred sixty-four adolescents ages 14-18 years with
DM 1 were randomized for the trial (Weissberg-Benchell et al., 2016). Hood et el.
(2018) rendered the results from the Weissberg- Benchell et al. (2016) study. In the
one- year report from the PRP implementation, Hood et al. (2018) found there was a
decrease in diabetes distress in the PRP group compared to the control group.
Depressive symptoms and HbA1c levels remained stable in both groups with no
differences (Hood et al., 2018). Those individuals who received the PRP showed
better diabetes care management, which further documents adolescents with DM 1
benefit from various forms of therapy for diabetes management and depression (Hood
et al., 2018).
Studies strengths included similarities in study designs (longitudinal), usage of
validated screening tools, and low cost of implementation. Studies limitations included
small sample populations which led to low statistical power. Studies were also limited
to less diverse populations, which created low generalizability. Lastly, several studies
used a self-report tool which can lead to a response bias when evaluating the data
With an implementation of change at an organization, the IHI model for
improvement PDSA cycle was the framework for the project. This framework is easily
utilized in projects for improvement processes, as a goal of the project is to initiate
depression screening among the adolescents admitted with DKA with DM 1. During
the planning phase, stakeholders and I met to discuss implementation of the PHQ-9
screening tool for the population, as well as setting the clinical goal for implementation.
Implementation of the PHQ-9 was completed by the patients by wipeable sheet with dry
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erase then replicated into the electronic medical record (EMR) by the registered nurse
(RN).
To summarize, data in most articles did not provide large statistical significance
for depression among DM 1 adolescents, however indicated a clinical significance that
depression is a problem among adolescents with DM 1 affecting their daily care
management and QOL (Jaser et al., 2017). Marker et al. (2019) as well as Duffus et al.
(2019) found the group of individuals with DM I had an increase in depressive
symptoms, than those without DM I exhibiting an effect on metabolic control. As
depression and poor metabolic control continue to persist into late adolescence,
associations with worsening co-morbidities, as well as greater risk for poor care
management into adulthood (IPSAD, 2011).
Method
Design
This QI project used a prospective, descriptive design. This was the first PDSA
cycle in a quality improvement initiative utilizing a medical record review.
Implementation began February 15th with screenings initiated and data collection
occurring from February 15th through May 5th 2021.
Setting
The QI project occurred in a small, midwestern suburban pediatric hospital with
an eightbed PICU. The hospital serves approximately 382 patients, with 32 of those
beds for pediatrics. The hospital is located in a population of approximately 117,000
people with two medical centers, of which a children’s hospital is adjoined to one of
them.
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Sample
The sample for this QI project was purposeful of DKA admissions ages 12-18
years with inclusion criteria of English speaking, admitting diagnosis of DKA,
accommodation code of general status. Exclusion criteria was patients who were not
English speaking, developmental delay and DKA with diagnosis of DM 2/ HHS, new
onset diabetic without DKA.
Procedures
Education was presented to the nursing staff, residents and doctors on the floor,
and made available at our bulletin board in the nursing break room. A reminder sheet
was placed at the resident desk that stated the inclusion criteria: ages 12-18, English
speaking, admitting diagnosis of DKA, and accommodation code of general status. The
PICU resident added the nursing communication upon admission that stated “RN to
please complete the PHQ-9 depression screening once patient has reached general
status accommodation code”. In coordination with the PICU intensivists, hospitalists,
residents, unit manager, unit charge nurses, unit nurses and student PI, monitored to see
the PHQ-9 was completed once accommodation code of general status was given prior
to discharge from the hospital. The adolescents were given a wipeable copy of the
PHQ-9 to complete and the RN input the scores in the PHQ-9 flowsheet accessible via
the EMR. The depression cut off score was greater than or equal to 10 on the PHQ-9 or
positive for suicidal ideations. If the patient scored greater than or equal to 10, a
referral to behavioral health was made for the patient to be evaluated for depression
prior to discharge from the hospital. If the consult held up discharge, patients were
discharged home with a consult appointment made within that first week after
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discharge. Patients who scored positive for suicidal ideation on PHQ-9 received an
automatic behavioral health referral and seen while in the hospital. Completed PHQ-9
scores were collected, de-identified, and the data was recorded in an Excel spreadsheet.
Data was then placed into SPSS in which descriptive statistics used to analyze the
collected data.
Data Collection/Analysis
The data collected consisted of demographic information composed of age,
gender identification, and race. In addition, PHQ-9 scores, responses to PHQ-9, and
any behavioral health referrals were recorded. All data was deidentified and stored on a
password protected computer and removable drive owned by the primary investigator
(PI). Data analysis includes descriptive statistics that may show some possible
relationships between the variables of DKA and depression in pediatric patients with
Type 1 Diabetes.
Approval Processes
Approval was obtained from department administration. Additional approvals from
the Clinical Scholarship Project committee, the graduate school, and the hospital and
university’ institutional review board were obtained prior to data collection. The student
PI obtained a letter of support from the hospital as a Quality Improvement project to
proceed with IRB review at the university.
Results
Seven patients met the inclusion criteria for the project and had a PHQ-9
screening completed. The average score of the PHQ-9 was 9.29 with a standard
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deviation (SD) of 7. A score greater than or equal to 5 indicates depression, and
behavioral health referrals were given for scores greater than or equal to 10.
Demographics
The majority of the population was female and white. The sample contained 78%
white/Caucasian, 11% African American/ black, and 11% Hispanic/Latino. Patient ages
ranged from 12-17 years with a mean age of 14 years. A run chart was compiled from
the number of patients who completed the PHQ-9 (Table 2). The run chart identifies
those who met inclusion criteria indicated in blue, and the total number of screenings that
occurred over the three-month collection time frame.
Discussion
For this quality improvement project, the PDSA cycle framework was utilized.
The PHQ9 depression screening was administered for adolescents ages 12-18 years
who were admitted with new onset DM 1 in DKA in PICU. The screening rate of
patients who met inclusion criteria for this project was 78%. Although nine patients met
the requirements for the PHQ-9 screening, two adolescents were missed by the staff
RNs. Among the patients screened, four scored greater than or equal to 10 on the PHQ9 indicating depression, or 57% of the sample. While most studies state 25-30% of
adolescents with DM 1 have depression, the small sample size of this project suggests
that future PDSA cycles will need a larger sample size to increase validity (Marker et
al., 2019). While three adolescents were referred to behavioral health, one adolescent
who had suicidal ideations was discharged from our hospital for direct admission to an
outside hospital for inpatient psychiatric therapy.
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The QI project suggests a positive impact for patients. While reviewing results
of the PHQ-9 and providing education with the adolescents and parents, an opportunity
arose for the adolescents to discuss their feelings of depression with their parents.
During these care management discussions, three of the four adolescents stated they had
never been able to talk about these feelings asked about on the PHQ-9, and parents
were unaware of the struggles that their adolescents were having. An in-depth
discussion was held with the adolescent who was identified with suicidal ideations and
this patient was thankful that the screening had been completed because the patient did
not know how to tell the mother or sisters that these feelings were occurring. This
supports studies which discuss parents who are aware of their child’s depression take a
more active role in their care and management with coping strategies and support (Jaser
et al., 2017).
One barrier to this QI project was identified from staff nurses who stated they
had difficulty locating the PHQ-9 in the EMR for screening and subsequent increased
time to do so. Reminders were discussed with these nurses on a regular basis to
emphasize the importance of implementing the PHQ-9 as a service to our population.
Once more screenings showed positive depression rates in the sample, an attitude
change occurred. Another barrier was the ability to obtain an observation sitter upon the
identification of suicidal ideations with the patient. A floor nurse was pulled from the
floor to cover this sitter need for the remainder of the shift.

Limitations related

to this project included small sampling size. During the data collection phase, there
were several admissions that did not meet the inclusion criteria or missed the target age
by one year. Changing the inclusion criteria for the future PDSA cycles may increase
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the sample size. A goal for the next PDSA cycle would expand inclusion criteria of
adolescents to ages 11-18, admitted with DKA or new onset DM1 without DKA, and
HHS. Future PDSA cycles should include hospital protocols to account for those
patients who are at risk of suicide. While a suicide screening is completed on all
patients ages eight and older in the hospital setting, if this screening is missed because
the patient is obtunded upon admission, but later found to have suicidal ideations with
the PHQ-9 screening, there are no protocols in place to address a safety plan for the
patient.
Depression screening should be continued as the implementation did identify
positive depression screenings providing access to behavioral health care of adolescents
who met criteria. Advocating for behavioral health management by implementing a
depression screening with this higher risk population is supported by the Doctor of
Nursing Practice Essentials (AACN, 2006).
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Figure 1
PHQ-9

(Kroenke, Spitzer, & Williams, 2001)
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Figure 2
PHQ-9 Scoring Interpretation

(Kroenke, Spitzer & Williams, 2001)
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Table 1
Patient Demographic Characteristics
Patient Characteristic
Age (y)
Gender
Race

PHQ-9 Completion
PHQ-9 Score
Referral to behavioral health

Mean + SD or percent
14.4 + 1.74
56 % Female
44% Male
78% White (n= 5)
11% African American (n= 1)
11% Hispanic/Latino (n=1)
78%
9.29 + 7.135
100%
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Table 2
Run Chart- PHQ-9 Completion for those who met Inclusion Criteria
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